Main Sequence

Main Sequence is a venture capital firm founded in 2017 by Australia’s national science agency, CSIRO. The firm specializes in deep technology investments, aiming to bridge the gap between scientific research and commercialization. With over $1 billion managed across three funds, Main Sequence focuses on sectors such as artificial intelligence, energy storage, advanced manufacturing, and renewable energy. The firm primarily invests in seed to growth-stage companies, typically 2–3 years old, with deal sizes ranging from $5 million to $10 million. Main Sequence supports its portfolio companies by providing strategic partnerships, industry connections, and access to CSIRO’s research infrastructure. Their investments have created over 2,100 jobs and foster collaborations with 28 Australian universities and industry partners. The team is committed to addressing global challenges through science-driven innovation and reinvesting returns into scientific advancements.

Venture Capital & Private Equity Eveleigh, Australia ~26 employees

Work at Main Sequence in HR or recruiting? Claim this page

Employees
26
+13% in the 3 months to Sep 2026
Total funding
$500M
Last round Jul 2023
12-month attrition
10.9%
Tech: 0%
H1B sponsor
NA
Open jobs
2
Last 30 days

Headcount trend

Main Sequence went from 22 employees in Oct 2024 to 26 in Sep 2026. Apr to Sep 2026: 5 people joined, 0 left.

Funding rounds

Total funding$500M
Funding rounds3
Investors11

Org structure

Headcount by department

Other10
Operations6
Finance5
HR3
Marketing1
Design1

Main Sequence FAQ

How many employees does Main Sequence have?

Main Sequence has about 26 employees, up 13% over the 3 months to Sep 2026.

How much funding has Main Sequence raised?

Main Sequence has raised $500M in total funding.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.